Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
NCT ID: NCT02068118
Description: Serious and Other \[Not Including Serious\] Adverse Events were not monitored/assessed in this study which did not involve any investigational medicinal product. Deaths and hospitalizations constituted the study outcome measures and efficacy criteria. Therefore, they were not considered a result from an Adverse Event and were not reported as Serious Adverse Events.
Frequency Threshold: 0
Time Frame: During their study participation, patients were only examined once by the investigating cardiologists at the study centers, at the time of their enrolment and randomization. After this Inclusion Visit, patients were followed up via four telephone calls, conducted by clinical study technicians (at 15 days, 6, 12 and 18 months, all ±15 days).
Study: NCT02068118
Study Brief: Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard Care/Tele-cardiology * Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists. * Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period. 90 None 0 0 0 0 View
Tele-cardiology Group/Tele-cardiology \- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses. Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure. \- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period. 99 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):